Research Facility

Baltimore, Maryland 21287

1 studies enrolling now · 6 studies all time

What they study most

Arrhythmias, Glioblastoma, Hepatocellular Carcinoma (HCC), Hypoactive Sexual Desire Disorder, Osteoarthritis, Ulcerative Colitis

Studies at this site

• Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC — Recruiting now
• Phase 2 Study of Durvalumab (MEDI4736) in Patients With Glioblastoma — Completed
• Long Term Safety of 125 mg Per Day of Oral Azimilide in Patients With Implantable Cardioverter Defibrillator (ICDs) — Completed
• A Double Blind Study for the Treatment of Acute Ulcerative Colitis — Completed
• Safety of Buprenorphine Transdermal Patch (BTDS) in Osteoarthritis Pain: a 52-Week Extension Phase — Stopped early
• Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women — Completed